Equities

Beijing Wandong Medical Technology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Beijing Wandong Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)16.09
  • Today's Change0.01 / 0.06%
  • Shares traded3.50m
  • 1 Year change-1.95%
  • Beta0.9642
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Beijing Wandong Medical Technology Co Ltd is a China-based company principally engaged in the research, development, manufacturing, sales and after-sales service of medical imaging equipment. The Company operates through two segments. The Medical Device Sales segment is mainly involved in the research, development, manufacturing and sales of digital imaging equipment. The Medical Services and Others segment is primarily engaged in the provision of radiological diagnostic services and remote imaging services. The Company's products include digital X-ray imaging systems, magnetic resonance imaging systems, X-ray computed tomography imaging systems, vascular interventional treatment systems, medical diagnostic X-ray machines, digital mammography machines and others. The Company distributes its products within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)1.62bn
  • Net income in CNY14.41m
  • Incorporated1997
  • Employees1.19k
  • Location
    Beijing Wandong Medical Technology Co LtdNo. 3 BuildingNo. 9 Courtyard, Jiuxianqiao East RoadChaoyang DistrictBEIJING 100015ChinaCHN
  • Phone+86 1 084569688
  • Fax+86 1 084575717
  • Websitehttps://www.wandong.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Haohai Biological Tech Co Ltd2.52bn384.21m10.06bn2.16k28.711.94--3.991.651.6510.8324.490.35121.537.841,169,728.004.944.585.965.2669.1370.3914.0714.673.24--0.065642.371.6410.951.042.55-1.8614.87
Qingdao Haier Biomedical Co Ltd2.26bn255.88m10.33bn2.81k40.072.39--4.560.81440.81447.2113.640.40084.315.12806,199.104.6810.875.9214.1245.3149.2111.6724.082.41--0.020528.140.128817.67-9.7115.03-5.5321.16
Xiangyu Medical Co Ltd773.93m73.51m11.01bn2.34k143.715.43--14.230.47890.47895.0712.670.25481.0111.40330,597.702.358.543.2610.1765.9866.789.2228.370.9871--0.238732.49-0.171711.71-54.68-4.4183.55--
Shanghai Microport EP MedTech Co Ltd458.70m52.26m11.11bn500.00212.526.20--24.210.1110.1110.97473.810.23951.336.85917,403.002.730.90842.910.957958.2464.9511.394.0910.17--0.00320.0025.5128.61815.36--35.67--
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.31bn1.19k965.192.41--6.980.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
Sansure Biotech Inc1.67bn271.49m11.65bn2.35k45.411.63--6.980.44270.44272.4512.310.18521.042.46711,687.902.5021.182.8124.3773.7068.6013.4940.514.49--0.171625.7444.7831.89-24.2347.5065.28--
Eyebright Medical Technlgy (Bjng) Co Ltd1.48bn360.97m11.73bn2.29k32.214.17--7.931.881.887.7114.530.40481.893.34644,799.409.9010.5011.5412.0462.9175.1324.4531.923.2824.660.175320.1148.2448.5127.7742.2518.40--
Shandong Weigao Orthopaedic Devce Co Ltd1.48bn266.86m11.94bn2.07k44.742.93--8.090.66720.66723.7010.180.29190.77985.17714,278.405.369.006.5811.0564.2274.0718.3724.984.28--0.001122.9013.18-1.5999.22-12.72-3.40--
TINAVI Medical Technologies Co Ltd274.20m-159.01m11.95bn307.00--9.57--43.59-0.3493-0.34930.60352.740.16732.187.63893,155.40-10.37-8.02-11.54-9.1670.0969.64-62.01-63.512.94-15.750.1408---14.85-4.8722.54--12.71--
Vcanbio Cell & Gene Engineering Corp Ltd1.47bn74.75m11.98bn2.01k155.463.23--8.140.16470.16473.297.930.27781.922.35730,874.401.071.241.511.7667.2968.073.854.201.604.900.02190.00-0.27052.71-5.7315.09-11.35--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.25bn377.82m12.12bn832.0031.553.06--9.683.123.1210.2732.100.26941.563.661,515,185.007.9415.389.1016.8768.1075.3829.4541.854.36--0.004346.521.6129.301.9628.7858.5335.76
Data as of Feb 10 2026. Currency figures normalised to Beijing Wandong Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.15%Per cent of shares held by top holders
HolderShares% Held
Hwabao WP Fund Management Co., Ltd.as of 31 Dec 202413.79m2.55%
China Southern Asset Management Co., Ltd.as of 30 Jun 20253.94m0.73%
Golden Eagle Asset Management Co., Ltd.as of 30 Jun 20252.97m0.55%
GF Fund Management Co., Ltd.as of 30 Jun 20252.77m0.51%
China Asset Management Co., Ltd.as of 30 Jun 20252.48m0.46%
The Vanguard Group, Inc.as of 07 Jan 20262.10m0.39%
Nuode Asset Management Co., Ltd.as of 30 Jun 20251.93m0.36%
Guotai Asset Management Co., Ltd.as of 30 Jun 20251.23m0.23%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 20251.14m0.21%
China Universal Asset Management Co., Ltd.as of 30 Jun 2025884.87k0.16%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.